BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15693022)

  • 1. Gender differences in glutathione metabolism in Alzheimer's disease.
    Liu H; Harrell LE; Shenvi S; Hagen T; Liu RM
    J Neurosci Res; 2005 Mar; 79(6):861-7. PubMed ID: 15693022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione metabolism during aging and in Alzheimer disease.
    Liu H; Wang H; Shenvi S; Hagen TM; Liu RM
    Ann N Y Acad Sci; 2004 Jun; 1019():346-9. PubMed ID: 15247041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased synthetic capacity underlies the age-associated decline in glutathione content in Fisher 344 rats.
    Liu RM; Dickinson DA
    Antioxid Redox Signal; 2003 Oct; 5(5):529-36. PubMed ID: 14580307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of gamma-glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging.
    Liu RM
    J Neurosci Res; 2002 May; 68(3):344-51. PubMed ID: 12111865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidants in erythrocytes in aging and dementia].
    Biomed Khim; 2013; 59(4):443-51. PubMed ID: 24502142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of erythrocyte glutathione, cysteine and glutathione synthetase in alcoholic and non-alcoholic cirrhosis.
    Loguercio C; Del Vecchio Blanco C; Coltorti M; Nardi G
    Scand J Clin Lab Invest; 1992 May; 52(3):207-13. PubMed ID: 1411253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus.
    Murakami K; Kondo T; Ohtsuka Y; Fujiwara Y; Shimada M; Kawakami Y
    Metabolism; 1989 Aug; 38(8):753-8. PubMed ID: 2569661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of gamma-glutamylcysteine synthetase and glutathione synthetase in erythrocytes by high-performance liquid chromatography with fluorimetric detection.
    Nardi G; Cipollaro M; Loguercio C
    J Chromatogr; 1990 Aug; 530(1):122-8. PubMed ID: 1980497
    [No Abstract]   [Full Text] [Related]  

  • 10. HPLC analysis of human erythrocytic glutathione forms using OPA and N-acetyl-cysteine ethyl ester: evidence for nitrite-induced GSH oxidation to GSSG.
    Michaelsen JT; Dehnert S; Giustarini D; Beckmann B; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(28):3405-17. PubMed ID: 19665947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
    Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
    Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte glutathione metabolism in human chronic fluoride toxicity.
    Saralakumari D; Rao PR
    Biochem Int; 1991 Jan; 23(2):349-57. PubMed ID: 1677568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of glutathione in Alzheimer's disease.
    Saharan S; Mandal PK
    J Alzheimers Dis; 2014; 40(3):519-29. PubMed ID: 24496077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal glutathione content and some related enzyme activities in the fetal erythrocytes.
    Lestas AN; Rodeck CH
    Br J Haematol; 1984 Aug; 57(4):695-702. PubMed ID: 6146350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer's disease.
    Cecchi C; Latorraca S; Sorbi S; Iantomasi T; Favilli F; Vincenzini MT; Liguri G
    Neurosci Lett; 1999 Nov; 275(2):152-4. PubMed ID: 10568522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer's disease.
    Peter C; Braidy N; Zarka M; Welch J; Bridge W
    Curr Alzheimer Res; 2015; 12(4):298-313. PubMed ID: 25731620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cysteine in the regulation of blood glutathione-protein mixed disulfides in rats treated with diamide.
    Di Simplicio P; Giannerini F; Giustarini D; Lusini L; Rossi R
    Toxicol Appl Pharmacol; 1998 Jan; 148(1):56-64. PubMed ID: 9465264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrimidine nucleotides do not affect the enzymes of glutathione biosynthesis.
    Zerez CR; Lachant NA; Tanaka KR
    Enzyme; 1985; 34(2):94-7. PubMed ID: 2867897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with organic acidaemias have an altered thiol status.
    Salmi H; Leonard JV; Lapatto R
    Acta Paediatr; 2012 Nov; 101(11):e505-8. PubMed ID: 22849335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.